Health X Platform members approve composite scheme at 37th AGM
- Members approved a composite scheme of arrangement involving four entities including Microsec Resources and Innogrow Technologies.
- Financial statements for FY26 were adopted without any qualifications in auditor reports.
- Mrs. Anjana Dikshit was re-appointed as an Independent Director for a second five-year term.
- Special resolutions authorized borrowing limits, asset mortgages, and related-party transactions.

*this image is generated using AI for illustrative purposes only.
Health X Platform Limited, formerly known as Sastasundar Ventures Limited, concluded its 37th Annual General Meeting on September 28, 2026. The meeting was conducted via Video Conferencing and Other Audio Visual Means, with 104 members participating in the proceedings.
The primary focus of the meeting was the approval of a Composite Scheme of Arrangement and Amalgamation. This strategic restructuring involves Health X Platform, Microsec Resources Private Limited, Innogrow Technologies Limited, and Sastasundar Healthbuddy Limited. The scheme aims to consolidate digital healthcare assets under a unified corporate structure.
Strategic Digital Assets Highlighted
During the address, Chairman B. L. Mittal emphasized the company's strengthened position through its key digital platforms. The company outlined its portfolio of digitally driven services designed to enhance healthcare access and supply chain efficiency:
- SastaSundar App: A consumer-centric platform for seamless healthcare access.
- RetailerShakti App: A B2B supply chain solution empowering pharmacies.
- JitoHealth.com: A platform promoting generic medicines with AI-driven recommendations.
- SastaSundar Health & Happiness Podcast: An initiative to combat misinformation with trusted information.
Composite Scheme Details
The Board approved the composite scheme on June 10, 2026, following recommendations from the Committee of Independent Directors and the Audit Committee. The arrangement is subject to approvals from stock exchanges, SEBI, NCLT, RBI, and respective shareholders and creditors. NOC applications have been filed with the stock exchanges and RBI.
Resolutions Passed
Members transacted both ordinary and special business items as per the notice dated August 7, 2026. Key resolutions included the adoption of audited financial statements for FY26 and various borrowing authorizations.
| Resolution Type | Item | Status |
|---|---|---|
| Ordinary | Adopt Audited Financial Statements (Standalone & Consolidated) for FY26 | Passed |
| Ordinary | Re-appointment of Mrs. Abha Mittal (retiring by rotation) | Passed |
| Special | Re-appointment of Mrs. Anjana Dikshit as Independent Director (5 years) | Passed |
| Special | Approve overall borrowing limit under Section 180(1)(c) | Passed |
| Special | Authorize creation of mortgage or charge on assets | Passed |
| Special | Authorize loans, guarantees, security, and investments | Passed |
| Special | Authorize loans/guarantees/security under Section 185 | Passed |
Governance and Compliance
The meeting was chaired by Mr. B. L. Mittal, with all directors and key managerial personnel present. The statutory auditors' report contained no qualifications, reservations, or adverse remarks. Similarly, the secretarial audit report was clean. Voting results will be disclosed to stock exchanges and company websites within two working days.
Historical Stock Returns for Health X Platform
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.21% | -4.95% | -3.88% | +2.74% | -8.11% | 0.0% |
What is the expected timeline for NCLT and SEBI approvals for the Composite Scheme of Arrangement?
How will the consolidation of digital healthcare assets impact Health X Platform's competitive positioning against other Indian health-tech startups?
What specific revenue synergies are projected from integrating Microsec Resources and Innogrow Technologies into the unified structure?
































